SCHEMBL24750122

SCHEMBL24750122

CCc1c(-c2nnc(SCc3ccc(C=O)cc3)o2)[nH]c2ccc(Cl)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ NPSR1 Q6W5P4 1/20 0.45
▸ QPCT Q16769 1/20 0.41
▸ MAPK1 P28482 2/20 0.41
▸ HTT P42858 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ TERT O14746 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ HPGD P15428 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24750370 0.89 MAPT (0.46) MAPTMEN1KMT2ANPSR1QPCT
SCHEMBL21801494 0.89 MAPT (0.48) MAPTMEN1KMT2ANPSR1QPCT
SCHEMBL21801466 0.88 MAPT (0.51) MAPTMEN1KMT2ANPSR1MAPK1
SCHEMBL21801554 0.86 MAPT (0.52) MAPTMEN1KMT2ANPSR1QPCT
SCHEMBL21801488 0.79 CNR1 (0.46) MAPTMEN1KMT2ANPSR1QPCT
SCHEMBL21801696 0.77 MAPT (0.50) MAPTMEN1KMT2ANPSR1QPCT
SCHEMBL21801522 0.77 TDP1 (0.47) MAPTLMNASMN1; SMN2TDP1TERT
SCHEMBL21801673 0.77 QPCT (0.47) MAPTMEN1KMT2ANPSR1QPCT
SCHEMBL21801473 0.76 NPC1 (0.46) NPSR1QPCTMAPK1HTTLMNA
SCHEMBL21801461 0.76 MAPK1 (0.50) MAPTMEN1KMT2ANPSR1QPCT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220257569-A1 INDOLE-OXADIAZOLE COMPOUNDS AND THEIR THERAPEUTIC USE THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) 2022-08-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220257569-A1 INDOLE-OXADIAZOLE COMPOUNDS AND THEIR THERAPEUTIC USE CNR2, GPR119, CNR1 MAPT 2269/4885MEN1 4146/4885KMT2A 2952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback